Sungeeta Agrawal
Pediatric Endocrinology · Charlotte, NCNPI 1851669980
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 30.1% of the total. 2025 is the largest year on record at $943, 4.5 times the $210 reported in 2019.
Across 70 payments — averaging $37.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$788
- AbbVie$563
- Ultragenyx Pharmaceutical Inc.$214
- Tandem Diabetes Care, Inc.$170
- Sanofi-aventis U.S. LLC$166
- Dexcom, Inc.$117
- plus $601 from 12 others
Across 3 payments — averaging $5737.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$17K
What the payments were for
- Food & beverage$2,49495%
- Education$1255%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $788 |
| AbbVie | 27 | $563 |
| Ultragenyx Pharmaceutical Inc. | 3 | $214 |
| Tandem Diabetes Care, Inc. | 2 | $170 |
| Sanofi-aventis U.S. LLC | 5 | $166 |
| Dexcom, Inc. | 2 | $117 |
| Biomarin Pharmaceutical Inc. | 1 | $116 |
| Insulet Corporation | 5 | $94 |
| BETA Bionics, Inc. | 1 | $73 |
| Neurocrine Biosciences, Inc. | 2 | $63 |
| Ascendis Pharma Endocrinology Inc | 3 | $63 |
| Pfizer | 2 | $60 |
| Sequel Med Tech, LLC | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Aegerion Pharmaceuticals, Inc. | 1 | $23 |
| Endo USA, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Norditropin$357
- Lupron Depot$226
- t:slim X2 Insulin Pump with Control-IQ$156
- CRYSVITA$154
- Wegovy$103
How this compares
$2,619 in reported general payments places this provider in the 75th percentile of 46 pediatric endocrinology providers in North Carolina.
See all pediatric endocrinology providers in North Carolina →
Other pediatric endocrinology in Charlotte
- Mark VanderwelCharlotte$42K
- Jakub MieszczakCharlotte$34K
- Henry RohrsCharlotte$4K
- Lisa HouchinCharlotte$2K
- Mark ParkerCharlotte$606
- Christopher BlundenCharlotte$465
- Frances BullardCharlotte$145
- Malaka JacksonCharlotte$131
- Jennifer LawChapel Hill$40K
- Nina JainSanford$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.